Severe nephrotic syndrome in a patient with Schönlein-Henoch purpura: complete remission after cyclosporin A.
Schmaldienst
S
S
Department of Medicine, University of Vienna, Austria.
Winkler
S
S
Breiteneder
S
S
Hörl
W H
WH
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use*; D004656:Enalapril / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases; D011695:IgA Vasculitis / Q000150:complications* / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008148:Lovastatin / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D010956:Plasmapheresis; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria / Q000150:complications / Q000188:drug therapy
D000806:Angiotensin-Converting Enzyme Inhibitors; D004791:Enzyme Inhibitors; D007166:Immunosuppressive Agents; D004656:Enalapril; D016572:Cyclosporine; D008148:Lovastatin; D006903:Hydroxymethylglutaryl CoA Reductases; D011241:Prednisone; D008775:Methylprednisolone